Lehrstuhl für Pharmazeutische Chemie


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Synthetic Route to Phenyl Diazenes and Pyridazinium Salts from Phenylazosulfonates (2021) Gradl S, Köckenberger J, Oppl J, Schiller M, Heinrich M Journal article Radiosynthesis and evaluation of F-18-labeled dopamine D-4-receptor ligands (2021) Willmann M, Ermert J, Prante O, Hübner H, Gmeiner P, Neumaier B Journal article 2-Fluoro-5-nitrophenyldiazonium: A Novel Sanger-Type Reagent for the Versatile Functionalization of Alcohols (2021) Fischer O, Heinrich M Journal article Sensitization to amphetamine psychostimulant effect: A key role for ventral tegmental area neurotensin type 2 receptors and MAP kinase pathway (2021) Voyer D, Einsiedel J, Gmeiner P, Lévesque D, Rompré PP Journal article Homobivalent Dopamine D2Receptor Ligands Modulate the Dynamic Equilibrium of D2Monomers and Homo-and Heterodimers (2021) Ullmann T, Gienger M, Budzinski J, Hellmann J, Hübner H, Gmeiner P, Weikert D Journal article Presynaptic vesicular accumulation is required for antipsychotic efficacy in psychotic-like rats (2021) Uzuneser T, Weiss EM, Dahlmanns J, Kalinichenko L, Amato D, Kornhuber J, Alzheimer C, et al. Journal article, Original article Binding pathway determines norepinephrine selectivity for the human β1AR over β2AR (2021) Xu X, Kaindl J, Clark MJ, Hübner H, Hirata K, Sunahara RK, Gmeiner P, et al. Journal article, Original article Visualization of β-adrenergic receptor dynamics and differential localization in cardiomyocytes (2021) Huang W, Manglik A, Venkatakrishnan AJ, Laeremans T, Feinberg EN, Sanborn AL, Kato HE, et al. Journal article, Original article Fluorescent ligands for dopamine D-2/D-3 receptors (2020) Allikalt A, Purkayastha N, Flad K, Schmidt M, Tabor A, Gmeiner P, Hübner H, Weikert D Journal article, Original article Interference with ERK-dimerization at the nucleocytosolic interface targets pathological ERK1/2 signaling without cardiotoxic side-effects (2020) Tomasovic A, Brand T, Schanbacher C, Kramer S, Hümmert MW, Godoy P, Schmidt-Heck W, et al. Journal article